Placeholder image of a protein
Icon representing a puzzle

805: Ferredoxin Pentamer Design

Closed since over 12 years ago

Intermediate Overall Design Symmetry

Summary


Created
November 05, 2013
Expires
Max points
100
Description

In this puzzle you can redesign a protein that was originally designed in the Baker Lab. This ferredoxin-like fold is very stable as a monomer, and the Baker Lab is trying to redesign it to form a symmetric pentamer. The backbone is locked for most of the protein, but you can mutate surface residues to improve the pentamer interface. You can also design a 10 residue extension at the N- or C-terminus to improve the binding interface between monomer units; reset the puzzle to alternate between the extended N- and C-terminus versions. This puzzle also includes a Residue IE filter, which monitors that all PHE, TYR, and TRP residues are scoring well.

Top groups


  1. Avatar for Gargleblasters 11. Gargleblasters 10 pts. 12,738
  2. Avatar for SETI.Germany 13. SETI.Germany 6 pts. 12,658
  3. Avatar for Eὕρηκα! Heureka! 14. Eὕρηκα! Heureka! 4 pts. 12,635
  4. Avatar for Repro-men 15. Repro-men 3 pts. 12,569
  5. Avatar for Russian team 16. Russian team 2 pts. 12,557
  6. Avatar for Natural Abilities 17. Natural Abilities 2 pts. 12,513
  7. Avatar for Curtin Crowd 18. Curtin Crowd 1 pt. 12,333
  8. Avatar for Deleted group 19. Deleted group pts. 12,243
  9. Avatar for FoldIt@Netherlands 20. FoldIt@Netherlands 1 pt. 12,187

  1. Avatar for Museka
    1. Museka Lv 1
    100 pts. 13,039
  2. Avatar for Ch Garnier 2. Ch Garnier Lv 1 99 pts. 13,034
  3. Avatar for christioanchauvin 3. christioanchauvin Lv 1 97 pts. 12,986
  4. Avatar for dembones 4. dembones Lv 1 95 pts. 12,947
  5. Avatar for gitwut 5. gitwut Lv 1 94 pts. 12,939
  6. Avatar for MurloW 6. MurloW Lv 1 92 pts. 12,926
  7. Avatar for phi16 7. phi16 Lv 1 91 pts. 12,907
  8. Avatar for O Seki To 8. O Seki To Lv 1 89 pts. 12,900
  9. Avatar for bertro 9. bertro Lv 1 87 pts. 12,895
  10. Avatar for hpaege 10. hpaege Lv 1 86 pts. 12,856

Comments